Stay updated on PF-06801591 Dose Escalation in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PF-06801591 Dose Escalation in Solid Tumors Clinical Trial page.

Latest updates to the PF-06801591 Dose Escalation in Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedDifference0.3%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.2%
- Check15 days agoChange DetectedDifference0.4%
- Check22 days agoChange DetectedThe page has undergone significant updates, including the removal of detailed descriptions of the Phase 1 study protocol for PF-06801591 and the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference14%
- Check29 days agoChange DetectedThe web page has been updated to include a new version number, indicating a revision from v2.14.3 to v2.14.4, and it now provides helpful links for obtaining contact information for study centers.SummaryDifference0.7%
- Check37 days agoChange DetectedThe page has been updated to include information on Ovarian Epithelial Cancer while removing references to Transitional Cell Carcinoma. Additionally, the revision number has been updated from v2.14.2 to v2.14.3.SummaryDifference0.3%
Stay in the know with updates to PF-06801591 Dose Escalation in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-06801591 Dose Escalation in Solid Tumors Clinical Trial page.